header
June 19 - June 26

In This Issue
Registration open for MMA’s 168th Annual Membership Meeting (Sep 10-12)
FDA to revise vaccine fact sheets on increased risk of myocarditis
MaineCare announces continuation of policies upon end of Civil Emergency
Maine Secretary of State seeking physician volunteers
Maine DHHS announces free text alert program to prevent overdose deaths
Associated Press: Nearly all COVID deaths in US are now among unvaccinated
AAMC Report Reinforces Mounting Physician Shortage
#VaccinateME - Maine Community Action Partnership: #GiveitaSHAHT!
Top JAMA and JAMA Network articles
MMA Mary Cushman, MD Award for Humanitarian Service
MAINE LEGISLATURE
Legislative Advocacy Update: Maine Legislature returns this week
Federal Government Affairs
Federal Advocacy Scan: Infrastructure spending bill caught up in political fight
UPCOMING EVENTS
Upcoming Specialty Society Meetings
AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
SUPPORT for ME Training and Technical Assistance Initiative
Working with Children & Adolescents? Maine Pediatric & Behavioral Health Partnership (MPBHP) Webinar Series (July thru December 2nd Wednesday of month)
Register Now: Governor Mills’ 3rd Annual Opioid Response Summit on July 15th
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Physician (BC/BE in Family Medicine) - Strong Area Health Center
Physician (BC/BE in Family Medicine) - Richmond Area Health Center
Contract Clinical Advisor - Healthcare Coalition of Maine
Medical Director
Pediatrician

 
Search Back Issues



 


 

 

 

 

 


Follow Us:
FDA to revise vaccine fact sheets on increased risk of myocarditis

The FDA announced Friday they will revise the patient and provider fact sheets for the Moderna and Pfizer-BioNTech COVID-19 vaccines regarding the suggested increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination.

The decision comes after the CDC Advisory Committee on Immunization Practices (ACIP) on Wednesday identified a “likely association” between the two mRNA vaccines and cases of myocarditis and pericarditis.

According to the FDA, the update follows an extensive review of information and the discussion by CDC’s Advisory Committee on Immunization Practices meeting on Wednesday.

·   Reports describe the illness predominantly in males under 30 followingthe second dose of an mRNA vaccine, with most cases appearing to resolve themselves.

·    More than 150 million people have received either the Pfizer or Moderna vaccine, making the 1,200-plus documented cases rare.

·    The warning in the Fact Sheets for Healthcare Providers Administering Vaccines notes that reports of adverse events suggest increased risks of myocarditis and pericarditis, particularly following the second dose and with onset of symptoms within a few days after vaccination.

·   Recipients and Caregivers for these vaccines note that vaccine recipients should seek medical attention right away if they have chest pain, shortness of breath, or feelings of having a fast-beating, fluttering, or pounding heart after vaccination.

·    The FDA and CDC are monitoring the reports, collecting more information, and will follow-up to assess longer-term outcomes over several months.

NBC News: Benefits of COVID-19 vaccination outweigh risks of heart inflammation in young people

 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©